Researchers analyzed 153 participants aged 18-62 years (mean age, 36 years) diagnosed with BED and enrolled in the US Binge Eating Treatment and Recovery program between 2020 and 2023. Participants ...

Depression is a mental health disorder characterized by a recurrent or persistent sadness and a loss of interest in activities that were previously deemed pleasurable, sometimes accompanied by changes ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...

Different types of depression affect the body in different ways. Atypical, energy-related depression raises the risk of diabetes, while melancholic depression increases the likelihood of heart disease ...

Already an established treatment for drug-resistant epilepsy, the ketogenic diet is now drawing interest as a potential adjunctive therapy for TRD, schizophrenia, and bipolar disorder.

Objective To synthesise meta-analytic outcomes from randomised controlled trials examining exercise effects on depression and anxiety across all population groups, including children and adults with ...

Lumateperone significantly improved depression severity in MDD patients unresponsive to prior treatment, showing efficacy in phase 3 trials. FDA approved lumateperone as an adjunctive treatment for ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...